-
New Dyskinesia Drug Advances to Final Stage of FDA Review Process
January 10, 2017
… accepted for review the New Drug Application (NDA) for a dyskinesia therapy. Dyskinesia -- characterized by uncontrolled, involuntary …
-
Utility of a Novel Nicotinic Receptor Agonist for Treating Levodopa-induced Dyskinesia
… benefit in a pre-clinical model of L-DOPA induced dyskinesia. If our nicotinic agonist demonstrates efficacy … but we currently lack direct evidence that it will improve dyskinesia in pre-clinical or clinical studies. The purpose …
-
Too Much or Not Enough: Dyskinesia and ''Off'' Time in Parkinson's (Replay)
August 17, 2023
… We will replay a popular webinar on “off” time and dyskinesia. Our expert panelists discuss these common … time is when symptoms return between medication doses. Dyskinesia is uncontrolled, involuntary movement. We cover …
-
Clinical Study: Drug Targeting Serotonin May Help Stop Dyskinesia
June 12, 2012
… announcing encouraging clinical results for a drug to treat dyskinesia in people with Parkinson’s disease (PD). The … think that serotonin neurons may play a role in causing dyskinesia. Here’s the basic idea behind this novel …
-
Too Much or Not Enough: Dyskinesia and “Off” Time in Parkinson's (Webinar Replay)
August 23, 2023
… Gifford leads a discussion on common Parkinson’s issues —dyskinesia and "off" time — and how to treat them. Panelist … explains the uncontrolled, involuntary movement called dyskinesia that may occur with medication use and …
-
Ask the MD: What is Dyskinesia and Can it be Controlled in Parkinson's Patients? [VIDEO]
September 4, 2012
… Specialist, Maurizio Facheris, MD, responds to questions on dyskinesias experienced as a result of Parkinson's disease …